Clinical Trial Update: Effect of Sublingually Generated S-nitroso-N-acetylcysteine on Systemic Blood Pressure. [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial evaluated the effect of sublingually generated S-nitroso-N-acetylcysteine on systemic blood pressure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertension

Drugs mentioned

• S-nitroso-N-acetylcysteine (S-nitroso-N-acetylcysteine)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Hypertension, Cardiovascular Diseases | EARLY_Phase 1 | Status: COMPLETED